organ
respond
multipl
way
microbi
infect
pathogen
invas
tipic
trigger
inflammatori
respons
acut
phase
protein
app
key
role
pentraxin
ptx
famili
highli
conserv
app
play
part
host
defens
infect
larger
protein
famili
simpli
name
pentraxin
creactiv
protein
crp
serum
amyloid
protein
saa
sap
known
short
pentraxin
although
high
app
level
broadli
associ
bacteri
infect
grow
bodi
evid
reveal
increas
ptx
crp
sap
express
upon
viral
infect
furthermor
crp
ptx
sap
shown
potenti
diagnost
marker
predictor
diseas
outcom
likewis
measur
app
level
valuabl
determin
efficaci
antivir
therapi
vaccin
practic
point
view
abil
app
reduc
viral
infect
observ
sever
virushost
model
prompt
investig
effort
assess
role
acut
phase
respons
protein
immunoregulatori
molecul
potenti
therapeut
reagent
work
aim
present
overview
app
respons
viral
infect
review
current
knowledg
field
live
organ
prepar
face
extern
aggress
injuri
pathogen
invas
one
arm
host
defens
respons
activ
call
acut
phase
respons
apr
includ
product
inflammatori
cytokin
number
protein
creactiv
protein
crp
serum
amyloid
protein
saa
sap
pentraxin
ptx
collect
term
acut
phase
protein
app
app
present
anim
group
studi
arthropod
vertebr
nonetheless
research
app
conduct
mammalian
model
crp
classifi
short
pentraxin
group
identifi
protein
around
synthes
liver
crp
blood
level
rise
notabl
patient
undergo
inflammatori
respons
number
diseas
condit
includ
cancer
human
crp
tend
form
pentamer
structur
current
accept
balanc
monomer
crp
pentamer
crp
state
determin
function
serum
amyloid
saa
serum
amyloid
p
sap
also
releas
circul
correl
antimicrobi
antiinflammatori
activ
protein
often
found
amyloid
deposit
atherosclerosi
diseas
crp
sap
known
interact
complement
compon
result
activ
complement
cascad
ptx
larger
protein
form
multimer
structur
ptx
product
variou
cell
type
stimul
microbi
infect
ptx
normal
store
blood
cell
neutrophil
readi
releas
challeng
bacteri
viral
pathogen
pentraxin
regard
promin
member
pentraxin
superfamili
dramat
increas
blood
level
upon
bacteri
viral
infect
involv
number
function
immun
inflamm
sever
aspect
app
regard
inflammationrel
disord
review
other
focu
set
respons
invad
virus
discuss
presenc
app
blood
specif
tissu
may
alter
viral
infect
associ
enhanc
host
innat
immun
respons
differenti
modul
crp
ptx
sap
upon
microbi
challeng
make
protein
ideal
marker
diseas
prognosi
discrimin
bacteri
viral
etiolog
furthermor
chang
app
express
administr
antivir
drug
vaccin
observ
suggest
possibl
use
app
report
efficaci
antivir
treatment
virusinfect
organ
repres
exampl
app
modul
viru
infect
summar
tabl
consist
correl
diseas
progress
elev
level
app
report
viral
diseas
affect
respiratori
tract
increas
app
concentr
serum
organ
infect
virus
caus
respiratori
ill
reach
hundredsthousandfold
healthi
sampl
increas
level
crp
found
patient
infect
virul
type
influenza
viru
thu
human
influenza
diseas
outcom
associ
enhanc
product
crp
highest
crp
level
correl
sever
symptom
even
mortal
crp
induct
may
vari
amongst
differ
avian
influenza
viru
subtyp
power
inductor
crp
cytokin
product
subtyp
fact
highli
pathogen
influenza
subtyp
induc
high
serum
level
crp
associ
fatal
clinic
outcom
shown
good
correl
durat
fever
children
respiratori
tract
infect
although
seem
could
regard
good
refer
confirm
viral
caus
recent
studi
combin
data
analysi
crp
saa
becam
best
predictor
sever
respiratori
diseas
hospit
children
influenza
viru
infect
mice
saa
concentr
serum
rise
severalhundr
fold
three
day
speci
chang
acut
phase
protein
level
dramat
crp
saa
increment
respect
report
pig
infect
swine
influenza
overal
good
correl
sever
diseas
crp
serum
concentr
infect
swine
influenza
viru
saa
demonstr
use
report
diseas
develop
pig
coinfect
viral
bacteri
pathogen
particular
saa
serum
level
appear
best
indic
diseas
progress
swine
influenza
case
infect
respiratori
tract
may
trigger
upregul
app
express
lung
bronchi
extrahepat
upregul
saa
also
report
porcin
reproduct
respiratori
syndrom
viru
prrsv
infect
pig
particularli
lung
infect
pandem
influenza
virus
caus
increas
level
saa
nonhuman
host
saa
play
part
host
respons
equin
influenza
saa
concentr
peak
acut
phase
diseas
good
correl
appear
clinic
sign
observ
appli
veterinari
practic
elev
concentr
saa
may
serv
marker
respiratori
viral
infect
cattl
phenomenon
term
acut
phase
respons
would
expect
develop
differ
fashion
long
term
viral
diseas
compar
acut
viral
infect
hepat
amongst
preval
chronic
viral
infect
human
hepat
b
c
virus
target
liver
main
produc
crp
serum
amyloid
protein
discuss
thu
surpris
patient
undergo
chronic
hepat
c
infect
show
higher
level
crp
healthi
individu
similarli
high
level
crp
report
chronic
hepat
b
patient
associ
liver
damag
fact
crp
consid
use
predictor
mortal
hepat
b
infect
individu
suffer
cirrhosi
way
elev
plasma
level
consid
risk
factor
develop
liver
carcinoma
hcv
patient
retrovirus
human
immunodefici
viru
hiv
wellknown
capac
establish
long
last
infect
bodi
hivexpos
infant
show
elev
crp
level
inflammatori
marker
like
interleukin
persist
high
level
crp
patient
receiv
antiretrovir
therapi
associ
diseas
progress
higher
probabl
clinic
failur
upregul
app
upon
retroviru
infect
report
speci
well
felin
immunodefici
viru
fiv
infect
cat
determin
sap
concentr
plasma
complementari
measur
viral
rna
level
predict
diseas
progress
mani
virus
known
persist
host
nervou
system
establish
latent
infect
aujeszki
diseas
pseudorabi
patholog
pig
caus
herp
viru
result
neurolog
sign
fatal
clinic
outcom
pseudorabi
viru
infect
mous
model
determin
acut
inflammatori
respons
infect
high
level
crp
produc
sever
tissu
number
system
infect
caus
arthropodborn
virus
signific
impact
human
health
sever
hemorrhag
case
dengu
crp
level
elev
well
inflammatori
cytokin
includ
howev
author
refer
reliabl
indic
dengu
diseas
sever
inflammatori
respons
chikungunya
viru
chikv
infect
associ
higher
amount
patient
acut
infect
rodentborn
hantavirus
diseas
sever
durat
hospit
stay
infer
high
plasma
level
appear
hemorrhag
fever
symptom
like
mammal
bird
possess
innat
immun
system
first
barrier
defens
pathogen
therefor
bird
capabl
mount
rapid
respons
upon
viral
infect
magnitud
respons
may
vari
among
speci
avian
influenza
viru
caus
rapid
elev
saa
level
chicken
duck
may
explain
lesser
mortal
rate
less
sever
diseas
duck
compar
chicken
viral
pathogen
bird
also
chang
app
pattern
like
infecti
bursal
diseas
viru
ibdv
induc
increas
chang
infect
chicken
previou
report
suggest
app
respons
viral
challeng
common
poultri
primit
adapt
immun
fish
consid
reli
heavili
innat
immun
respons
fact
app
like
crp
multigen
famili
fish
although
current
knowledg
app
role
fish
viral
diseas
still
limit
relev
crp
saa
variou
antimicrobi
defens
function
recogn
two
import
virus
affect
fish
farm
viral
hemorrhag
septicemia
viru
vhsv
spring
viremia
carp
viru
svcv
shown
alter
crp
gene
express
zebrafish
signific
upregul
mrna
express
crp
gene
isoform
observ
zebrafish
day
infect
vhsv
svcv
parallel
transcript
activ
crp
gene
promot
histon
methyl
shown
increas
day
day
postinfect
svcv
protein
level
proteom
analysi
blood
svcvinfect
zebrafish
reveal
peak
isoform
express
hpi
return
rapidli
basal
level
similar
respons
observ
carp
infect
herpesviru
cyhv
peak
serum
concentr
crp
alreadi
hpi
declin
day
rock
bream
sap
profil
also
modul
iridoviru
infect
peak
sap
level
liver
infect
fish
detect
day
postinfect
taken
togeth
aforement
find
highlight
involv
app
rapid
antivir
respons
teleost
fish
use
app
therapeut
agent
fish
attract
possibl
support
experiment
evid
crp
sap
potenti
becom
wide
rang
antimicrobi
compound
due
abil
restrict
bacteri
viral
replic
intraperiton
administr
recombin
sap
shown
protect
carp
iridoviru
diseas
whether
costefficaci
therapeut
use
recombin
app
would
meet
requir
fish
farm
industri
matter
debat
administr
antivir
vaccin
induc
chang
profil
pentraxin
tabl
often
magnitud
respons
smaller
respons
correspond
viru
infect
case
influenza
viru
vaccin
crp
respons
vaccin
normal
weak
nevertheless
number
studi
explor
potenti
measur
chang
app
level
assess
protect
efficaci
given
vaccin
respect
import
note
correl
crp
level
efficaci
vaccin
may
vari
depend
host
condit
particularli
age
elder
patient
respond
herp
zoster
vaccin
lower
level
crp
taken
indic
vaccin
failur
similar
agedepend
behavior
occur
hivinfect
patient
inflammatori
marker
correl
mortal
differ
among
infant
adult
serum
concentr
crp
hiv
infect
associ
viral
load
therefor
efficaci
therapeut
vaccin
similar
situat
observ
nonhuman
speci
crp
respons
mice
influenza
viru
vaccin
also
affect
age
neonat
mice
show
higher
crp
level
adult
individu
adjuv
substanc
ad
vaccin
boost
host
immun
respons
thu
adjuv
may
becom
import
factor
influenc
app
respons
vaccin
rabbit
respons
associ
acut
phase
protein
either
posit
neg
depend
vaccineadjuv
combin
fact
adjuv
formul
lead
rapid
increas
crp
level
later
return
basal
level
inject
consid
sign
acut
inflamm
caus
vaccin
similar
situat
report
veterinari
prevent
care
studi
commerci
vaccin
two
viral
diseas
dog
nobivac
induc
increas
serum
level
crp
went
parallel
increas
antibodi
titer
canin
distemp
viru
canin
parvoviru
work
romiszewski
colleagu
suggest
crp
profil
could
reliabl
measur
efficaci
vaccin
dog
regard
nonmammalian
host
saa
propos
candid
marker
vaccin
efficaci
poultri
chicken
vaccin
newcastl
diseas
viru
show
saa
increas
correl
higher
antibodi
titer
present
wide
recogn
capac
app
limit
viral
replic
spread
within
host
function
part
earli
defens
respons
induct
specif
antibodi
respons
pathogen
sever
way
app
could
affect
viral
replic
discuss
follow
section
mechan
action
wide
report
antivir
activ
app
base
capac
attach
viru
particl
subsequ
block
viruscel
interact
human
sap
bind
influenza
viru
inhibit
virusinduc
hemagglutin
interestingli
sap
bind
virusinfect
cell
uninfect
cell
suggest
select
effect
ptx
sap
viral
infect
analyz
influenza
viru
mutant
resist
inhibitori
effect
amino
acid
residu
hemagglutinin
ha
respons
viru
sensit
identifi
provid
evid
recognit
ha
mice
treatment
influenza
virusinfect
mice
human
success
reduc
viral
load
increas
surviv
infect
anim
hint
potenti
therapeut
applic
pentraxin
recent
year
use
recombin
ptx
antivir
drug
emerg
distinct
possibl
respect
han
colleagu
demonstr
protect
effect
intranas
administr
recombin
murin
coronaviru
aforement
studi
gene
knockout
technolog
appli
investig
antivir
respons
pentraxin
show
higher
suscept
mous
hepat
coronaviru
mhv
mice
moreov
observ
could
bind
mhv
particl
vitro
prompt
vivo
studi
mice
treat
recombin
achiev
better
clearanc
viru
lung
sap
bind
influenza
viru
ha
result
inhibit
infect
mice
higher
surviv
observ
intranas
administr
sap
likewis
antihepat
activ
saa
associ
inhibitori
effect
hcv
entri
bind
saa
viru
particl
follow
studi
corrobor
saa
protect
cell
hcv
infect
block
step
prior
viru
entri
cell
worth
mention
bind
app
viru
particl
alway
end
inhibit
viral
replic
contrari
bind
ross
river
viru
seem
facilit
viru
entri
cell
anoth
instanc
provir
action
app
porcin
saa
report
enhanc
effect
prrsv
replic
vitro
pentraxin
inhibit
enhanc
viral
replic
fulli
understood
vitro
antivir
effect
pentraxin
often
relat
viru
bind
capac
vivo
effect
app
viral
infect
usual
mediat
activ
innat
immun
system
interferon
pathway
lead
discrep
vitro
vivo
role
pentraxin
bind
crp
cell
membran
impair
subsequ
viru
attach
entri
cell
bind
seem
depend
affin
crp
cholesterolrich
lipid
raft
cell
membran
would
explain
antivir
activ
zebrafish
crp
svcv
human
crp
bind
rapidli
activ
monocyt
calciumdepend
way
bind
last
long
crp
quickli
detach
cell
go
back
basal
condit
antivir
action
app
also
link
activ
autophagi
autophagi
defens
mechan
cell
allow
remov
intracellular
microbi
pathogen
disrupt
cell
membran
crp
would
trigger
format
autophag
vesicl
part
cell
defens
mechan
evid
relationship
upregul
crp
autophagi
report
renal
cell
carcinoma
correl
express
crp
protein
involv
autophagi
present
research
gap
relationship
crp
autophagi
virusinfect
cell
address
futur
innat
immun
system
serv
rapid
first
wave
defens
invad
pathogen
immunomodulatori
role
app
interact
innat
immun
cell
report
human
crp
interfer
migrat
macrophag
rais
suggest
crp
may
assist
recruit
macrophag
site
tissu
injuri
monomer
crp
bind
lipid
raft
stimul
product
proinflammatori
cytokin
likewis
crp
bind
cell
membran
also
activ
complement
cascad
serum
amyloid
protein
also
regulatori
activ
innat
immun
inflammatori
cytokin
well
product
saa
liver
trigger
effect
cytokin
respons
microbi
infect
although
antivir
activ
seem
restrict
hcv
discuss
earlier
close
connect
express
crp
product
establish
fish
mammal
measur
circul
level
cytokin
app
well
character
pattern
associ
specif
diseas
condit
regard
use
tool
assist
diagnosi
infecti
diseas
differenti
bacteri
viral
origin
diseas
particularli
measur
serum
crp
level
recommend
distinguish
bacteri
viral
diseas
patholog
result
febril
condit
children
immunoassay
test
myxoviru
mxa
crp
base
clinic
diagnost
protocol
determin
bacteri
viral
etiolog
acut
respiratori
infect
higher
blood
level
crp
use
differenti
bacteri
viral
gastrointestin
infect
therefor
avoid
unnecessari
antibiot
therapi
combin
high
level
crp
saa
indic
bacteri
infect
case
infecti
mononucleosi
elev
saa
point
viral
infect
addit
identif
bacteri
viral
origin
diseas
determin
crp
concentr
shown
distinguish
viral
dengu
protozoan
malaria
infect
patient
similar
clinic
sign
rare
case
app
analysi
appli
differenti
diagnost
two
virus
respiratori
infect
analysi
crp
profil
contribut
valid
diagnost
influenza
viru
infect
rule
rhinoviru
infect
sever
studi
stress
util
app
biomark
diseas
consequ
determin
app
level
virusinfect
patient
establish
instrument
evalu
efficaci
antivir
drug
instanc
reduc
crp
level
good
indic
efficaci
interferonribavirin
combin
therapi
hcvinfect
patient
saa
crp
concentr
elev
cat
receiv
interferon
therapi
felin
immunodefici
viru
felin
leukemia
viru
model
saacrp
level
taken
evid
innat
immun
system
activ
antivir
treatment
mice
hand
lower
level
saa
serum
associ
inhibit
influenza
viru
replic
oseltamivirtr
individu
due
rapid
increas
infect
high
crp
level
use
earli
marker
viral
diseas
fish
outcom
symptom
howev
could
use
differenti
diagnosi
sinc
viral
bacteri
infect
induc
upregul
crp
express
fish
despit
intens
research
conduct
app
past
decad
begin
understand
function
play
app
virusinfect
organ
evid
app
key
compon
antimicrobi
respons
often
involv
directli
indirectli
inhibit
viral
replic
spread
within
host
manag
get
insight
rang
antivir
activ
mani
open
question
remain
app
stimul
suffici
provid
primari
protect
viral
pathogenesi
innat
immun
system
train
keep
memori
app
respons
thu
activ
research
need
assess
full
potenti
app
therapeut
agent
viral
diseas
well
biomark
efficaci
antivir
treatment
sever
final
conclus
drawn
bodi
knowledg
field
crp
express
upregul
broad
rang
human
viru
infect
nonhuman
host
serum
amyloid
protein
saa
sap
main
app
alter
viral
infect
crp
wide
upregul
app
upon
antivir
vaccin
antivir
activ
app
vitro
associ
virusbind
capac
app
use
diagnost
tool
larg
depend
virushost
situat
